Current status of drug research and development in acute myeloid leukemia and the consideration in pivotal clinical trial design

doi:10.3969/j.issn.1672-3384.2021.07.018

WANG Jian-xiang, XU Ying-yong

Clinical Medication Journal ›› 2021, Vol. 19 ›› Issue (7) : 84-89.

PDF(697 KB)

Clinical Medication Journal ›› 2021, Vol. 19 ›› Issue (7) : 84-89. DOI: 10.3969/j.issn.1672-3384.2021.07.018

Drug and Clinic

Current status of drug research and development in acute myeloid leukemia and the consideration in pivotal clinical trial design

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 19(7): 84-89 https://doi.org/10.3969/j.issn.1672-3384.2021.07.018

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(697 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-02-26	2021-07-05
Issue Date
2021-07-05

Please choose a citation manager

Content to export